Advertisement

5: Injectable progestin contraception and vaginal infection among south african women participating in the VOICE trial

      Data are limited on the potential impact of the injectable progestin contraceptives (IPC) norethisterone enanthate on risk of vaginal infections. We assessed whether users of two common IPC (depot medroxyprogesterone acetate [DMPA] and norethisterone enanthate [NET-EN]) differed in their risk for bacterial vaginosis (BV) and Trichomonas vaginalis (TV).
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect